Clinical Trial Update: Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating abiraterone acetate with or without cabazitaxel in metastatic castration-resistant prostate cancer; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-10